KARA KATZ: Open Payments
NPI 1801462304 · HOLLY SPRINGS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$732 in 42 payments from 15 companies in 2025. Trend: 2023 $684 · 2024 $430 · 2025 $732
Food & beverage: $732
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $196 |
| Novo Nordisk Inc | 8 | $145 |
| Lilly USA, LLC | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $45 |
| Exact Sciences Corporation | 2 | $35 |
| Eisai Inc. | 2 | $34 |
| Amgen Inc. | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| PFIZER INC. | 1 | $21 |
Products named: VRAYLAR, MOUNJARO, UBRELVY, QULIPTA, Ozempic, CAPLYTA, Wegovy, The Cologuard Plus Collection Kit.
Industry payments across NC — which companies pay providers there.
